# Estrogen, HDL, and Coronary Heart Disease in Women

> **NCT00083824** · PHASE2,PHASE3 · COMPLETED · sponsor: **Tufts University** · enrollment: 309 (actual)

## Conditions studied

- Cardiovascular Diseases
- Coronary Disease
- Heart Diseases
- Coronary Arteriosclerosis

## Interventions

- **DRUG:** Estrogens, Conjugated (USP)
- **DRUG:** Medroxyprogesterone 17-Acetate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00083824
- **Lead sponsor:** Tufts University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-03
- **Primary completion:** 2007-02
- **Final completion:** 2007-02
- **Target enrollment:** 309 (ACTUAL)
- **Last updated:** 2016-04-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00083824

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00083824, "Estrogen, HDL, and Coronary Heart Disease in Women". Retrieved via MORVS 2026-10-19 from https://api.morvs.ai/clinical/NCT00083824. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*